Top

Published in:

Open Access 01-06-2013 | Review

Clinical review: Statins and trauma - a systematic review

Authors: Jan O Jansen, Janet M Lord, David R Thickett, Mark J Midwinter, Daniel F McAuley, Fang Gao

Published in: Critical Care | Issue 3/2013

Abstract

Statins, in addition to their lipid-lowering properties, have anti-inflammatory actions. The aim of this review is to evaluate the effect of pre-injury statin use, and statin treatment following injury. MEDLINE, EMBASE, and CENTRAL databases were searched to January 2012 for randomised and observational studies of statins in trauma patients in general, and in patients who have suffered traumatic brain injury, burns, and fractures. Of 985 identified citations, 7 (4 observational studies and 3 randomised controlled trials (RCTs)) met the inclusion criteria. Two studies (both observational) were concerned with trauma patients in general, two with patients who had suffered traumatic brain injury (one observational, one RCT), two with burns patients (one observational, one RCT), and one with fracture healing (RCT). Two of the RCTs relied on surrogate outcome measures. The observational studies were deemed to be at high risk of confounding, and the RCTs at high risk of bias. Three of the observational studies suggested improvements in a number of clinical outcomes in patients taking statins prior to injury (mortality, infection, and septic shock in burns patients; mortality in trauma patients in general; mortality in brain injured patients) whereas one, also of trauma patients in general, showed no difference in mortality or infection, and an increased risk of multi-organ failure. Two of three RCTs on statin treatment in burns patients and brain injured patients showed improvements in E-selectin levels and cognitive function. The third, of patients with radial fractures, showed no acceleration in fracture union. In conclusion, there is some evidence that pre-injury statin use and post-injury statin treatment may have a beneficial effect in patients who have suffered general trauma, traumatic brain injury, and burns. However, these studies are at high risk of confounding and bias, and should be regarded as 'hypothesisgenerating'. A well-designed RCT is required to determine the therapeutic efficacy in improving outcomes in this patient population.

Mathers CD, Loncar D: Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006, 3: e442. 10.1371/journal.pmed.0030442PubMedCentralCrossRefPubMed

Stahel PF, Smith WR, Moore EE: Role of biological modifiers regulating the immune response after trauma. Injury 2007, 38: 1409-1422. 10.1016/j.injury.2007.09.023CrossRefPubMed

Moore FA, Sauaia A, Moore EE, Haenel JB, Burch JM, Lezotte DC: Postinjury multiple organ failure: A bimodal phenomenon. J Trauma 1996, 40: 501-510. discussion 510-512 10.1097/00005373-199604000-00001CrossRefPubMed

Tsukamoto T, Chanthaphavong RS, Pape HC: Current theories on the pathophysiology of multiple organ failure after trauma. Injury 2010, 41: 21-26. 10.1016/j.injury.2009.07.010CrossRefPubMed

Osborn TM, Tracy JK, Dunne JR, Pasquale M, Napolitano LM: Epidemiology of sepsis in patients with traumatic injury. Crit Care Med 2004, 32: 2234.PubMed

Nast-Kolb D, Aufmkolk M, Rucholtz S, Obertacke U, Waydhas C: Multiple organ failure still a major cause of morbidity but not mortality in blunt multiple trauma. J Trauma 2001, 51: 835. 10.1097/00005373-200111000-00003CrossRefPubMed

Brun-Buisson C: The epidemiology of the systemic inflammatory response. Intensive Care Med 2000,26(Suppl 1):S64-74.CrossRefPubMed

Angus DC, Wax RS: Epidemiology of sepsis: An update. Crit Care Med 2001,29(7 Suppl):S109-116.CrossRefPubMed

Chow CC, Clermont G, Kumar R, Lagoa C, Tawadrous Z, Gallo D, Betten B, Bartels J, Constantine G, Fink MP, Billiar TR, Vodovotz Y: The acute inflammatory response in diverse shock states. Shock 2005, 24: 74-84. 10.1097/01.shk.0000168526.97716.f3CrossRefPubMed

10.

Lenz A, Franklin GA, Cheadle WG: Systemic inflammation after trauma. Injury 2007, 38: 1336-1345. 10.1016/j.injury.2007.10.003CrossRefPubMed

11.

Partrick DA, Moore EE, Moore FA, Biffl WL, Barnett CC: Release of anti-inflammatory mediators after major torso trauma correlates with the development of postinjury multiple organ failure. Am J Surg 1999, 178: 564-569. 10.1016/S0002-9610(99)00240-8CrossRefPubMed

12.

Jastrow KM III, Gonzalez EA, McGuire MF, Suliburk JW, Kozar RA, Iyengar S, Motschall DA, McKinley BA, Moore FA, Mercer DW: Early cytokine production risk stratifies trauma patients for multiple organ failure. J Am Coll Surg 2009, 209: 320-331. 10.1016/j.jamcollsurg.2009.05.002CrossRefPubMed

13.

Hranjec T, Swenson BR, Dossett LA, Metzger R, Flohr TR, Popovsky KA, Bonatti HJ, May AK, Sawyer RG: Diagnosis-dependent relationships between cytokine levels and survival in patients admitted for surgical critical care. J Am Coll Surg 2010, 210: 833-844. 845-846 10.1016/j.jamcollsurg.2009.12.042PubMedCentralCrossRefPubMed

14.

Chao Y, Chen JS, Hunt VM, Kuron GW, Karkas JD, Liou R, Alberts AW: Lowering of plasma cholesterol levels in animals by lovastatin and simvastatin. Eur J Clin Pharmacol 1991,40(Suppl 1):S11-14.CrossRefPubMed

15.

Ma PT, Gil G, Südhof TC, Bilheimer DW, Goldstein JL, Brown MS: Mevinolin, an inhibitor of cholesterol synthesis, induces mrna for low density lipoprotein receptor in livers of hamsters and rabbits. Proc Natl Acad Sci USA 1986, 83: 8370-8374. 10.1073/pnas.83.21.8370PubMedCentralCrossRefPubMed

16.

Gao F, Linhartova L, Johnston AM, Thickett DR: Statins and sepsis. Br J Anaesth 2008, 100: 288-298. 10.1093/bja/aem406CrossRefPubMed

17.

Tonelli M, Lloyd A, Clement F, Conly J, Husereau D, Hemmelgarn B, Klarenbach S, McAlister FA, Wiebe N, Manns B, Alberta Kidney Disease Network: Efficacy of statins for primary prevention in people at low cardiovascular risk: A meta-analysis. CMAJ 2011, 183: E1189-1202. 10.1503/cmaj.101280PubMedCentralCrossRefPubMed

18.

Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ, JUPITER Study Group: Rosuvastatin to prevent vascular events in men and women with elevated c-reactive protein. N Engl J Med 2008, 359: 2195-2207. 10.1056/NEJMoa0807646CrossRefPubMed

19.

Lahera V, Goicoechea M, de Vinuesa SG, Miana M, de las Heras N, Cachofeiro V, Luño J: Endothelial dysfunction, oxidative stress and inflammation in atherosclerosis: Beneficial effects of statins. Curr Med Chem 2007, 14: 243-248. 10.2174/092986707779313381CrossRefPubMed

20.

Mitsios JV, Papathanasiou AI, Goudevenos JA, Tselepis AD: The antiplatelet and antithrombotic actions of statins. Curr Pharm Des 2010, 16: 3808-3814. 10.2174/138161210794455120CrossRefPubMed

21.

Ylä-Herttuala S, Bentzon JF, Daemen M, Falk E, Garcia-Garcia HM, Herrmann J, Hoefer I, Jukema JW, Krams R, Kwak BR, Marx N, Naruszewicz M, Newby A, Pasterkamp G, Serruys PW, Waltenberger J, Weber C, Tokgözoglu L: Stabilisation of atherosclerotic plaques. Position paper of the European Society of Cardiology (ESC) working group on atherosclerosis and vascular biology. Thromb Haemost 2011, 106: 1-19. 10.1160/TH10-12-0784CrossRefPubMed

22.

Guasti L, Marino F, Cosentino M, Cimpanelli M, Maio RC, Klersy C, Crespi C, Restelli D, Simoni C, Franzetti I, Gaudio G, Marnini P, Grandi AM, Lecchini S, Venco A: Simvastatin treatment modifies polymorphonuclear leukocyte function in high-risk individuals: A longitudinal study. J Hypertens 2006, 24: 2423-2430. 10.1097/01.hjh.0000251903.62804.77CrossRefPubMed

23.

Fischetti F, Carretta R, Borotto G, Durigutto P, Bulla R, Meroni PL, Tedesco F: Fluvastatin treatment inhibits leucocyte adhesion and extravasation in models of complement-mediated acute inflammation. Clin Exp Immunol 2004, 135: 186-193. 10.1111/j.1365-2249.2003.02358.xPubMedCentralCrossRefPubMed

24.

Hokama JY, Ritter LS, Davis-Gorman G, Cimetta AD, Copeland JG, McDonagh PF: Diabetes enhances leukocyte accumulation in the coronary microcirculation early in reperfusion following ischemia. J Diabetes Complications 2000, 14: 96-107. 10.1016/S1056-8727(00)00068-4CrossRefPubMed

25.

Weitz-Schmidt G: Statins as anti-inflammatory agents. Trends Pharmacol Sci 2002, 23: 482-487. 10.1016/S0165-6147(02)02077-1CrossRefPubMed

26.

Craig TR, Duffy MJ, Shyamsundar M, McDowell C, O'Kane CM, Elborn JS, McAuley DF: A randomized clinical trial of hydroxymethylglutarylcoenzyme a reductase inhibition for acute lung injury (the HARP study). Am J Respir Crit Care Med 2011, 183: 620-626. 10.1164/rccm.201003-0423OCCrossRefPubMed

27.

Shyamsundar M, McKeown ST, O'Kane CM, Craig TR, Brown V, Thickett DR, Matthay MA, Taggart CC, Backman JT, Elborn JS, McAuley DF: Simvastatin decreases lipopolysaccharide-induced pulmonary inflammation in healthy volunteers. Am J Respir Crit Care Med 2009, 179: 1107-1114. 10.1164/rccm.200810-1584OCPubMedCentralCrossRefPubMed

28.

Efron DT, Sorock G, Haut ER, Chang D, Schneider E, Mackenzie E, Cornwell EE III, Jurkovich GJ: Preinjury statin use is associated with improved in-hospital survival in elderly trauma patients. J Trauma 2008, 64: 66-73. discussion 73-74 10.1097/TA.0b013e31815b842aCrossRefPubMed

29.

Neal MD, Cushieri J, Rosengart MR, Alarcon LH, Moore EE, Maier RV, Minei JP, Billiar TR, Peitzman AB, Sperry JL, Inflammation and Host Response to Injury Investigators: Preinjury statin use is associated with a higher risk of multiple organ failure after injury: A propensity score adjusted analysis. J Trauma 2009, 67: 476-82. discussion 482-484 10.1097/TA.0b013e3181ad66bbPubMedCentralCrossRefPubMed

30.

Schneider EB, Efron DT, MacKenzie EJ, Rivara FP, Nathens AB, Jurkovich GJ: Premorbid statin use is associated with improved survival and functional outcomes in older head-injured individuals. J Trauma 2011, 71: 815-819. 10.1097/TA.0b013e3182319de5CrossRefPubMed

31.

Tapia-Perez J, Sanchez-Aguilar M, Torres-Corzo JG, Gordillo-Moscoso A, Martinez-Perez P, Madeville P, de la Cruz-Mendoza E, Chalita-Williams J: Effect of rosuvastatin on amnesia and disorientation after traumatic brain injury (NCT003229758). J Neurotrauma 2008, 25: 1011-1017. 10.1089/neu.2008.0554CrossRefPubMed

32.

Fogerty MD, Efron D, Morandi A, Guy JS, Abumrad NN, Barbul A: Effect of preinjury statin use on mortality and septic shock in elderly burn patients. J Trauma 2010, 69: 99-103. 10.1097/TA.0b013e3181df61b1CrossRefPubMed

33.

Akcay MN, Avkay G, Kiziltunc A, Ozturk G, Aydinli B: The effect of short-term treatment with atorvastatin on e-selectin levels in severely burned patients. Int J Clin Pharm Res 2005, 25: 65-69.

34.

Chan KA, Andrade SE, Boles M, Buist DS, Chase GA, Donahue JG, Goodman MJ, Gurwitz JH, LaCroix AZ, Platt R: Inhibitors of hydroxymethylglutarylcoenzyme A reductase and risk of fracture among older women. Lancet 2000, 355: 2185-2188. 10.1016/S0140-6736(00)02400-4CrossRefPubMed

35.

Meier CR, Schlienger RG, Kraenzlin ME, Schlegel B, Jick H: HMG-CoA reductase inhibitors and the risk of fractures. JAMA 2000, 283: 3205-3210. 10.1001/jama.283.24.3205CrossRefPubMed

36.

Nichols R, Hopman WM, Morton AR, Harman GJ, Holden RM: Statins are associated with a reduced risk of bone fracture in hemodialysis (HD) patients. Hemodial Int 2008, 12: 275-279. 10.1111/j.1542-4758.2008.00265.xCrossRefPubMed

37.

Pasco JA, Kotowicz MA, Henry MJ, Sanders KM, Nicholson GC: Statin use, bone mineral density, and fracture risk: Geelong osteoporosis study. Arch Intern Med 2002, 162: 537. 10.1001/archinte.162.5.537CrossRefPubMed

38.

Rejnmark L, Olsen ML, Johnsen SP, Vestergaard P, Sørensen HT, Mosekilde L: Hip fracture risk in statin users--a population-based danish case-control study. Osteoporos Int 2004, 15: 452-458.PubMed

39.

Rejnmark L, Vestergaard P, Mosekilde L: Statin but not non-statin lipid-lowering drugs decrease fracture risk: A nation-wide case-control study. Calcified Tissue Int 2006, 79: 27-36. 10.1007/s00223-006-0024-4CrossRef

40.

Schoofs MW, Sturkenboom MC, van der Klift M, Hofman A, Pols HA, Stricker BH: HMG-CoA reductase inhibitors and the risk of vertebral fracture. J Bone Miner Res 2004, 19: 1525-1530. 10.1359/JBMR.040607CrossRefPubMed

41.

Scranton RE, Young M, Lawler E, Solomon D, Gagnon D, Gaziano JM: Statin use and fracture risk: Study of a US veterans population. Arch Intern Med 2005, 165: 2007. 10.1001/archinte.165.17.2007CrossRefPubMed

42.

Wang PS, Solomon DH, Mogun H, Avorn J: HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients. JAMA 2000, 283: 3211-3216. 10.1001/jama.283.24.3211CrossRefPubMed

43.

Reid IR, Hague W, Emberson J, Baker J, Tonkin A, Hunt D, MacMahon S, Sharpe N: Effect of pravastatin on frequency of fracture in the LIPID study: Secondly analysis of a randomised controlled trial. Lancet 2001, 357: 509-512. 10.1016/S0140-6736(00)04042-3CrossRefPubMed

44.

Reid IR, Tonkin A, Cannon CP: Comparison of the effects of pravastatin and atorvastatin on fracture incidence in the PROVE IT-TIMI 22 trial--secondary analysis of a randomized controlled trial. Bone 2005, 37: 190-191. 10.1016/j.bone.2005.04.012CrossRefPubMed

45.

Bone HG, Kiel DP, Lindsay RS, Lewiecki EM, Bolognese MA, Leary ET, Lowe W, McClung MR: Effects of atorvastatin on bone in postmenopausal women with dyslipidemia: A double-blind, placebo-controlled, dose-ranging trial. J Clin Endocrinol Metab 2007, 92: 4671-4677. 10.1210/jc.2006-1909CrossRefPubMed

46.

Patil S, Holt G, Raby N, McLellan AR, Smith K, O'Kane S, Beastall G, Crossan JF: Prospective, double blind, randomized, controlled trial of simvastatin in human fracture healing. J Orthop Res 2009, 27: 281-285. 10.1002/jor.20572CrossRefPubMed

47.

Pfeifer R, Tarkin IS, Rocos B, Pape HC: Patterns of mortality and causes of death in polytrauma patients--has anything changed? Injury 2009, 40: 907-911. 10.1016/j.injury.2009.05.006CrossRefPubMed

48.

ClinicalTrials.gov: Statins for acutely injured lungs from sepsis (SAILS).[http://clinicaltrials.gov/ct2/show/NCT00979121]

49.

McAuley DF, Laffey JG, O'Kane CM, Cross M, Perkins GD, Murphy L, McNally C, Crealey G, Stevenson M, HARP-2 investigators on behalf of the Irish Critical Care Trials Grou: Hydroxymethylglutaryl-CoA reductase inhibition with simvastatin in acute lung injury to reduce pulmonary dysfunction (HARP-2) trial: Study protocol for a randomized controlled trial. Trials 2012, 13: 170. 10.1186/1745-6215-13-170PubMedCentralCrossRefPubMed

50.

Heeschen C, Hamm CW, Laufs U, Snapinn S, Böhm M, White HD, Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Investigators: Withdrawal of statins increases event rates in patients with acute coronary syndromes. Circulation 2002, 105: 1446-1452. 10.1161/01.CIR.0000012530.68333.C8CrossRefPubMed

51.

Le Manach Y, Godet G, Coriat P, Martinon C, Bertrand M, Fléron MH, Riou B: The impact of postoperative discontinuation or continuation of chronic statin therapy on cardiac outcome after major vascular surgery. Anesth Analg 2007, 104: 1326-1333. 10.1213/01.ane.0000263029.72643.10CrossRefPubMed

52.

Schouten O, Hoeks SE, Welten GM, Davignon J, Kastelein JJ, Vidakovic R, Feringa HH, Dunkelgrun M, van Domburg RT, Bax JJ, Poldermans D: Effect of statin withdrawal on frequency of cardiac events after vascular surgery. Am J Cardiol 2007, 100: 316-320. 10.1016/j.amjcard.2007.02.093CrossRefPubMed

53.

Pasternak RC, Smith SC, Bairey-Merz CN, Grundy SM, Cleeman JI, Lenfant C, National Heart, Lung and Blood Institute: ACC/AHA/NHLBI clinical advisory on the use and safety of statins. Circulation 2002, 106: 1024-1028. 10.1161/01.CIR.0000032466.44170.44CrossRefPubMed

54.

Bickel C, Rupprecht HJ, Blankenberg S, Espinola-Klein C, Rippin G, Hafner G, Lotz J, Prellwitz W, Meyer J, AtheroGene Group: Influence of HMG-CoA reductase inhibitors on markers of coagulation, systemic inflammation and soluble cell adhesion. Int J Cardiol 2002, 82: 25-31. 10.1016/S0167-5273(01)00576-9CrossRefPubMed

55.

Krysiak R, Okopień B, Herman Z: Effects of HMG-CoA reductase inhibitors on coagulation and fibrinolysis processes. Drugs 2003, 63: 1821-1854. 10.2165/00003495-200363170-00005CrossRefPubMed

56.

Bourcier T, Libby P: HMG coa reductase inhibitors reduce plasminogen activator inhibitor-1 expression by human vascular smooth muscle and endothelial cells. Arterioscler Thromb Vasc Biol 2000, 20: 556-562. 10.1161/01.ATV.20.2.556CrossRefPubMed

57.

Huhle G, Abletshauser C, Mayer N, Weidinger G, Harenberg J, Heene DL: Reduction of platelet activity markers in type II hypercholesterolemic patients by a HMG-CoA-reductase inhibitor. Thromb Res 1999, 95: 229-234. 10.1016/S0049-3848(99)00037-7CrossRefPubMed

58.

Mayer J, Eller T, Brauer P, Solleder EM, Schäfer RM, Keller F, Kochsiek K: Effects of long-term treatment with lovastatin on the clotting system and blood platelets. Ann Hematol 1992, 64: 196-201. 10.1007/BF01696223CrossRefPubMed

59.

Notarbartolo A, Davì G, Averna M, Barbagallo CM, Ganci A, Giammarresi C, La Placa FP, Patrono C: Inhibition of thromboxane biosynthesis and platelet function by simvastatin in type IIa hypercholesterolemia. Arterioscler Thromb Vasc Biol 1995, 15: 247-251. 10.1161/01.ATV.15.2.247CrossRefPubMed

Title: Clinical review: Statins and trauma - a systematic review
Authors: Jan O Jansen
Janet M Lord
David R Thickett
Mark J Midwinter
Daniel F McAuley
Fang Gao
Publication date: 01-06-2013
Publisher: BioMed Central
Published in: Critical Care / Issue 3/2013
Electronic ISSN: 1364-8535
DOI: https://doi.org/10.1186/cc12499

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Clinical review: Statins and trauma - a systematic review

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2013

Is early ventricular dysfunction or dilatation associated with lower mortality rate in adult severe sepsis and septic shock? A meta-analysis

Are clinical trials dealing with severe infection fitting routine practices? Insights from a large registry

Clinical review: Can we predict which patients are at risk of complications following surgery?

Impact of early versus late enteral nutrition on cell mediated immunity and its relationship with glucagon like peptide-1 in intensive care unit patients: a prospective study

Plasma levels of mitochondrial and nuclear DNA in patients with massive pulmonary embolism in the emergency department: a prospective cohort study

Intensive care sedation: the past, present and the future